Russia S&P Global Services PMI dipped from previous 53.2 to 51.2 in December
FXStreetDec 28, 2024 6:00 AM
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
September Fed Watch: A Policy Pivot That Could Make or Break the Bull Stock Market
TradingKey - The Fed’s September FOMC meeting is widely seen as locking in the first rate cut of 2025. Yet strategists at Morgan Stanley, JPMorgan, and Oppenheimer warn that as investors shift focus to slowing growth, a more cautious tone may replace bullish stock sentiment.TradingKey
15 hours ago
Effects of Interest Rate Cuts: Impact of Fed's September Meeting on Crypto Market
The Fed’s rate cut decision is a major bullish catalyst for crypto — but it comes with uncertainty. Investors should understand the economic rationale behind the move and adjust strategies accordingly. Staying flexible, informed, and disciplined is key to thriving in crypto’s fast-moving environmentTradingKey
17 hours ago
What hurdles lie ahead for any US-China TikTok deal?
By David Shepardson WASHINGTON, Sept 15 (Reuters) - Questions and potential hurdles surround a framework agreement announced on Monday between the U.S. and China that would switch short-video app TikTok to U.S.-controlled ownership, including whether any deal will comply with a 2024 law. U.S. andReuters
Tue, Sep 16
[U.S. IPO] Klarna Soars Over 40% on NYSE Debut, Testing Investor Appetite
TradingKey - On Wednesday, September 10th, Klarna (KLAR.US) made its debut on the New York Stock Exchange, opening at $52, which was 30% above its IPO price of $40. The stock experienced an intraday surge of up to 43% before closing up 14.55% at $45.82, giving the company a market valuation of $17 bTradingKey
Thu, Sep 11
.jpg)
From Ozempic to Wegovy: Growth and Risks Behind Novo Nordisk’s Q2 Performance
TradingKey - Novo Nordisk achieved revenue of $11.67 billion in Q2 of the 2025 fiscal year, a 19% increase year-over-year, but it fell short of market expectations. Growth was primarily driven by strong performance in obesity care and rare diseases.TradingKey
Thu, Aug 7
Tradingkey
